An international team, co-led by the Hospital Clínic-IDIBAPS, has identified four biomarkers that determine the risk of the recurrence of this canc...
A multicentre study led by the Hospital Clínic Barcelona-IDIBAPS demonstrates the efficacy of the CAR T-cell therapy ARI0002h in treating patients...
IDIBAPS’s Board of Governors has approved the promotion of Isabel Blanco, Carlos Fernández de Larrea and Gisela Sugranyes from Junior Group Leaders...
The activity, which is part of a new communication project, allowed visitors to learn about the cancer research carried out by the Institute's rese...
The Hospital Clínic-IDIBAPS has developed the first CAR T-cell therapy in Europe to treat multiple myeloma, the second most common type of blood ca...
On Thursday, 11 November, the Spanish Cancer Association (AECC) awarded the AECC 2021 Grants for Cancer Research at an event held at the organizati...
